Cutaneous T Cell Lymphoma: Responses in Phase 1 Trial of Combination Therapy with Liposomal Doxorubicin, Bortezomib, and Gemcitabine.
Year: 2006
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Navneet Dhillon, Srinivasa Bakkannagari, Chaan Ng, Joann Lim, Madeline Duvic, Razelle Kurzrock
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2557734048